-
Five-wicket Abbas has Lord's landmark as Pakistan set 389 to win second Test
-
Tadej Pogacar Out of Vuelta a Espana with Broken Collarbone and Concussion
-
Chelsea sign Argentina 'stopper Martinez from Villa
-
Iceland votes 'No' to resuming EU talks
-
Norway's churches hold services to late King Harald
-
Berlin Literary Guide: Book Launches, Festivals, and Readings Through August
-
Walmart Agrees to $50 Million Settlement Over Opioid Prescription Allegations
-
Nepal rescuers drill through debris towards trapped tunnel workers
-
Soundcore Liberty 5 Pro Review: Call Quality Redefines Value in Wireless Earbuds
-
Manhunt in Switzerland after fatal rave shooting
-
Lexus ES Review: Electric ES 350e Falls Short in Luxury Saloon Segment
-
'No' camp seen winning Iceland's EU referendum
-
Vietnamese coffee farmers ride China's durian wave
-
Nepal flood survivors return to ruins to salvage memories
-
Venezuela says retains 'sovereignty' in US oil deal
-
Killing of Palestinian children and teens by Israel surges in West Bank
-
NASA's Roman telescope set to launch on cosmic mapping mission
-
Educators keep 9/11 memory alive for next generation, 25 years on
-
Data center backlash scrambles US midterm politics
-
Venezuelans view US oil deal with doubt, hope
-
Emotional Federer inducted into tennis Hall of Fame
-
Gobena and Jepchirchir power to Sydney Marathon victories
-
Hovland takes solo lead as McIlroy surges at Tour Championship
-
Iceland in suspense after close EU vote
-
Djokovic 'prepared' for US Open bid for history
-
Wallabies hold on for victory in Argentina
-
Atletico down Sevilla to go top of La Liga
-
Juve notch second straight win, Fiorentina's centenary party falls flat
-
US deports right-wing provocateur Milo Yiannopoulos
-
Rybakina eases injury fears ahead of US Open
-
Niger junta says it is back in control after soldiers' mutiny
-
Djokovic kicks off latest Grand Slam quest under US Open lights
-
Erasmus calls Rennie barbs over Springbok scrumming 'nonsense'
-
'Sorry' De Zerbi won't panic after Spurs shambles
-
Lawrence's fifty leaves Pakistan facing record chase to level England series
-
UN, Nepal warn of climate threat after deadly floods
-
Netanyahu condemns settler attack in flashpoint West Bank village
-
USTA boss says structure of new player council not yet set
-
Munoz saves Iraola in Liverpool draw, big-spending Spurs lose again
-
Tiny Elversberg stun Leverkusen on Bundesliga debut, Dortmund beat Hamburg
-
Newcastle condemn dismal Spurs to second successive defeat
-
India and China have not named two new border meeting sites
-
Court orders JIPMER assessment of Durai Dayanidhi before money-laundering trial
-
Tamil Nadu and NUS agree to expand postgraduate and research links
-
Chennai councillors unite across parties to demand ward development funds
-
Tamil Nadu goalball team’s national silver highlights need for wider support
-
Tambaram civic groups seek action on eight long-pending issues
-
Rural Tamil Nadu students present 64 technology projects at IIT-M research park
-
Editorial questions Letitia James’ record as New York attorney general
-
Baladi Map app turns Lebanon’s local problems into a public record
Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group
MAULDIN, SC / ACCESS Newswire / October 9, 2025 / Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The transaction was completed as an all-cash sale.
"We made a decision to divest these assets in order to re-focus our business on our original mission of implementing an AI aided medical technology and virtual health care program in Africa through our majority owned subsidiary, AfiyaSasa Africa, LLC," said Mike O'Shea, Xcelerate's Chief Executive Officer. "Proceeds from this sale, combined with funds raised in a recent private placement, will allow Xcelerate to re-implement this business plan. We anticipate making additional announcements on the development of this business in the near future."
Investors and stakeholders are encouraged to stay updated on the latest developments by visiting the Company's website at https://xcelerate.global.
ABOUT XCELERATE INC.
In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology. For more information visit www.xcelerate.global or contact us at 854-900-2020 or email [email protected].
SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.
SOURCE: Xcelerate
View the original press release on ACCESS Newswire
W.Stewart--AT